These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26240043)

  • 1. [Pharmacologically induced unilateral mydriasis].
    Christensen MG; Mogensen AS; Mohey R
    Ugeskr Laeger; 2015 Jul; 177(30):. PubMed ID: 26240043
    [No Abstract]   [Full Text] [Related]  

  • 2. A benign cause for a unilateral dilated pupil in a critical care patient.
    Krovvidi HP; Thillaivasan A
    Eur J Anaesthesiol; 2008 Aug; 25(8):692-3. PubMed ID: 18339219
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
    Vogelberg C; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Hamelmann E; Engel M; Szefler S
    Respir Res; 2015 Feb; 16(1):20. PubMed ID: 25851298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.
    Maltais F; O'Donnell D; Gáldiz Iturri JB; Kirsten AM; Singh D; Hamilton A; Tetzlaff K; Zhao Y; Casaburi R
    Ther Adv Respir Dis; 2018; 12():1753465818755091. PubMed ID: 29439648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
    Sauer R; Hänsel M; Buhl R; Rubin RA; Frey M; Glaab T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tiotropium on heart rate variability in stable chronic obstructive pulmonary disease patients.
    Wu YK; Huang CY; Yang MC; Huang GL; Chen SY; Lan CC
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):100-5. PubMed ID: 24840562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, tolerability, and plasma exposure of tiotropium Respimat® in children and adults with cystic fibrosis.
    Konstan MW; Sharma A; Moroni-Zentgraf P; Wang F; Koker P
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):137-44. PubMed ID: 25380193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair
    Yildiz P; Bayraktaroglu M; Gorgun D; Secik F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2859-2867. PubMed ID: 27920513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium for the treatment of asthma: a drug safety evaluation.
    Kerstjens HA; O'Byrne PM
    Expert Opin Drug Saf; 2016 Aug; 15(8):1115-24. PubMed ID: 27279414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiriva Respimat--an oral inhalation spray for COPD.
    Med Lett Drugs Ther; 2015 Mar; 57(1465):49-50. PubMed ID: 25853581
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of tiotropium in patients with asthma.
    Dusser D; Ducharme FM
    Ther Adv Respir Dis; 2019; 13():1753466618824010. PubMed ID: 30795731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease.
    Yuan W; Nie S; Wang H; Xu Q; Jia N
    BMC Pulm Med; 2019 May; 19(1):88. PubMed ID: 31072407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium for the treatment of asthma in adolescents.
    Hamelmann E; Vogelberg C; Szefler SJ
    Expert Opin Pharmacother; 2017 Feb; 18(3):305-312. PubMed ID: 28110558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for inhaled anticholinergic therapy in asthma management?
    Parkey SM; Mospan CM
    JAAPA; 2017 Sep; 30(9):9-10. PubMed ID: 28858010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summaries for patients. Tiotropium and the treatment of chronic obstructive lung disease.
    Ann Intern Med; 2005 Sep; 143(5):I20. PubMed ID: 16144886
    [No Abstract]   [Full Text] [Related]  

  • 16. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR
    Wise RA; Calverley PM; Carter K; Clerisme-Beaty E; Metzdorf N; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():605-616. PubMed ID: 29497289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coma with bilateral mydriasis after use of transdermal scopolamine in ICU].
    Repéssé X; Geeraerts T; Pottecher J; Vigué B; Benhamou D; Duranteau J
    Ann Fr Anesth Reanim; 2007 Dec; 26(12):1070-2. PubMed ID: 17961969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety?
    McIvor RA
    Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.
    Kwak MS; Kim E; Jang EJ; Kim HJ; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2365-76. PubMed ID: 26604734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal scopolamine and perioperative anisocoria in craniofacial surgery: a report of 3 patients.
    Lee DT; Jenkins NL; Anastasopulos AJ; Volpe AG; Lee BT; Lalikos JF
    J Craniofac Surg; 2013 Mar; 24(2):470-2. PubMed ID: 23524718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.